Inactive Instrument

Other languages Amryt Pharma plc

Equities

AMYT

US03217L1061

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Chiesi Farmaceutici S.p.A. completed the acquisition of Amryt Pharma plc from Athyrium Capital Management, LP, Highbridge Capital Management, LLC, Joe Wiley, Rory Nealon, Ray Stafford and others.	23-04-11
Sector Update: Health Care Stocks Largely Struggle Monday	23-01-09
Top Midday Gainers	23-01-09
Sector Update: Health Care Stocks Struggling to Begin New Week	23-01-09
Sector Update: Health Care	23-01-09
Sector Update: Health Care Stocks Mixed Pre-Bell Monday	23-01-09
Rate Hike Clues, China Border Reopening Fuel Gains for US Equity Futures	23-01-09
Top Premarket Gainers	23-01-09
Amryt Pharma to be Acquired by Chiesi Farmaceutici	23-01-09
Amryt Pharma Says Phase 3 Trial of Cholesterol Disorder Treatment Met Primary Endpoint; Shares Gain Pre-Bell	23-01-05
Amryt Announces Positive Top Line Results from Phase 3 Pediatric Trial of Lomitapide in HoFH	23-01-05
Amryt Announces European Commission Approves Mycapssa® for the Treatment of Acromegaly	22-12-05
Amryt Pharma Says It Received New US Patent for Mycapssa	22-11-30
Amryt Pharma plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-03
Amryt Pharma plc Re-Affirms Revenue Guidance for the Year 2022	22-11-03
Amryt Pharma's Acromegaly Treatment Secures Positive Opinion on Orphan Designation From European Medicines Agency	22-10-18
Amryt Announces COMP Adopts Positive Opinion on Orphan Disease Designation for Mycapssa for Treatment of Acromegaly	22-10-18
Amryt Receives Reimbursement Approval from the Dutch Ministry of Health for Myalepta (Metreleptin)	22-10-17
Amryt Pharma Says UK Approves Marketing Authorization, Orphan Drug Designation for Filsuvez	22-09-08
Amryt Receives Marketing Authorisation Approval and Orphan Drug Designation for Filsuvez(R) in Great Britain	22-09-08

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Amryt Pharma plc

Equities

AMYT

US03217L1061

Other languages

Filters